Opt-in patient consent requirements for health information exchange correlate with more reported regulatory barriers, especially among less technologically advanced hospitals. Objectives: To (1) ...
Randomized Phase II Study of Bevacizumab in Combination With Carboplatin Plus Paclitaxel in Patients With Previously Untreated Advanced Mucosal Melanoma Supported by an administrative supplement to ...
Apathy, Nate C., and A Jay Holmgren. "Opt-in Consent Policies: Potential Barriers to Hospital Health Information Exchange." Special Issue on Health IT edited by Ilana Graetz. American Journal of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results